Literature DB >> 24441548

NFAT transcription factor regulation by urocortin II in cardiac myocytes and heart failure.

Stefanie Walther1, Sawsan Awad, Vassyl A Lonchyna, Lothar A Blatter.   

Abstract

Urocortin II (UcnII), a cardioactive peptide with beneficial effects in normal and failing hearts, is also arrhythmogenic and prohypertrophic. We demonstrated that cardiac effects are mediated by a phosphatidylinositol-3 kinase (PI3K)/Akt kinase (Akt)/endothelial nitric oxide synthase (eNOS)/nitric oxide (NO) signaling pathways. Nuclear factor of activated T-cells (NFAT) transcription factors play a key role in the regulation of gene expression in cardiac development, maintenance of an adult differentiated cardiac phenotype, and remodeling processes in cardiac hypertrophy and heart failure (HF). We tested the hypothesis that UcnII differentially regulates NFAT activity in cardiac myocytes from both normal and failing hearts through the PI3K/Akt/eNOS/NO pathway. Isoforms NFATc1 and NFATc3 revealed different basal subcellular distribution in normal and HF rabbit ventricular myocytes with a nuclear NFATc1 and a cytosolic localization of NFATc3. However, in HF, the nuclear localization of NFATc1 was less pronounced, whereas the nuclear occupancy of NFATc3 was increased. In normal myocytes, UcnII induced nuclear export of NFATc1 and attenuated NFAT-dependent transcriptional activity but did not affect the distribution of NFATc3. In HF UcnII facilitated nuclear export of both isoforms and reduced transcriptional activity. NFAT regulation was mediated by a PI3K/Akt/eNOS/NO signaling cascade that converged on the activation of several kinases, including glycogen synthase kinase-3β (GSK3β), c-Jun NH2-terminal kinase (JNK), p38 mitogen-activated kinase (p38), and PKG, resulting in phosphorylation, deactivation, and nuclear export of NFAT. In conclusion, while NFATc1 and NFATc3 reveal distinct subcellular distribution patterns, both are regulated by the UcnII-PI3K/Akt/eNOS/NO pathway that converges on the activation of NFAT kinases and NFAT inactivation. The data reconcile cardioprotective and prohypertrophic UcnII effects mediated by different NFAT isoforms.

Entities:  

Keywords:  NFAT; cardiac myocytes; heart failure; hypertrophy; nuclear factor of activated T-cells; urocortin

Mesh:

Substances:

Year:  2014        PMID: 24441548      PMCID: PMC3949047          DOI: 10.1152/ajpheart.00353.2013

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  61 in total

1.  Urocortin, a member of the corticotropin-releasing factor family, in normal and diseased heart.

Authors:  T Nishikimi; A Miyata; T Horio; F Yoshihara; N Nagaya; S Takishita; C Yutani; H Matsuo; H Matsuoka; K Kangawa
Journal:  Am J Physiol Heart Circ Physiol       Date:  2000-12       Impact factor: 4.733

Review 2.  NFAT signaling in vertebrate development.

Authors:  I A Graef; F Chen; G R Crabtree
Journal:  Curr Opin Genet Dev       Date:  2001-10       Impact factor: 5.578

Review 3.  Cardiovascular actions of CRH and urocortin: an update.

Authors:  D G Parkes; R S Weisinger; C N May
Journal:  Peptides       Date:  2001-05       Impact factor: 3.750

4.  Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor.

Authors:  K Lewis; C Li; M H Perrin; A Blount; K Kunitake; C Donaldson; J Vaughan; T M Reyes; J Gulyas; W Fischer; L Bilezikjian; J Rivier; P E Sawchenko; W W Vale
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-19       Impact factor: 11.205

5.  Upregulation of Na(+)/Ca(2+) exchanger expression and function in an arrhythmogenic rabbit model of heart failure.

Authors:  S M Pogwizd; M Qi; W Yuan; A M Samarel; D M Bers
Journal:  Circ Res       Date:  1999-11-26       Impact factor: 17.367

6.  Urocortin II: a member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors.

Authors:  T M Reyes; K Lewis; M H Perrin; K S Kunitake; J Vaughan; C A Arias; J B Hogenesch; J Gulyas; J Rivier; W W Vale; P E Sawchenko
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-27       Impact factor: 11.205

7.  Expression of urocortin and corticotropin-releasing factor receptor subtypes in the human heart.

Authors:  Yuichiro Kimura; Kazuhiro Takahashi; Kazuhito Totsune; Yasunari Muramatsu; Chika Kaneko; Andrew D Darnel; Takashi Suzuki; Masahito Ebina; Toshihiro Nukiwa; Hironobu Sasano
Journal:  J Clin Endocrinol Metab       Date:  2002-01       Impact factor: 5.958

8.  A role for the p38 MAP kinase pathway in the nuclear shuttling of NFATp.

Authors:  P Gómez del Arco; S Martínez-Martínez; J L Maldonado; I Ortega-Pérez; J M Redondo
Journal:  J Biol Chem       Date:  2000-05-05       Impact factor: 5.157

Review 9.  The PI3K-PDK1 connection: more than just a road to PKB.

Authors:  B Vanhaesebroeck; D R Alessi
Journal:  Biochem J       Date:  2000-03-15       Impact factor: 3.857

10.  Nuclear export of NF-ATc enhanced by glycogen synthase kinase-3.

Authors:  C R Beals; C M Sheridan; C W Turck; P Gardner; G R Crabtree
Journal:  Science       Date:  1997-03-28       Impact factor: 47.728

View more
  5 in total

Review 1.  The role of nuclear factor of activated T cells in pulmonary arterial hypertension.

Authors:  Rui Chen; Jinchuan Yan; Peijing Liu; Zhongqun Wang; Cuiping Wang; Wei Zhong; Liangjie Xu
Journal:  Cell Cycle       Date:  2017-01-19       Impact factor: 4.534

2.  Urocortin 2 stimulates nitric oxide production in ventricular myocytes via Akt- and PKA-mediated phosphorylation of eNOS at serine 1177.

Authors:  Stefanie Walther; Florentina Pluteanu; Susanne Renz; Yulia Nikonova; Joshua T Maxwell; Li-Zhen Yang; Kurt Schmidt; Joshua N Edwards; Paulina Wakula; Klaus Groschner; Lars S Maier; Joachim Spiess; Lothar A Blatter; Burkert Pieske; Jens Kockskämper
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-07-11       Impact factor: 4.733

3.  Comparative effects of urocortins and stresscopin on cardiac myocyte contractility.

Authors:  Catherine A Makarewich; Constantine D Troupes; Sarah M Schumacher; Polina Gross; Walter J Koch; David L Crandall; Steven R Houser
Journal:  J Mol Cell Cardiol       Date:  2015-07-29       Impact factor: 5.000

4.  NFAT4-dependent miR-324-5p regulates mitochondrial morphology and cardiomyocyte cell death by targeting Mtfr1.

Authors:  K Wang; D-L Zhang; B Long; T An; J Zhang; L-Y Zhou; C-Y Liu; P-F Li
Journal:  Cell Death Dis       Date:  2015-12-03       Impact factor: 8.469

5.  The effects of telmisartan on the nuclear factor of activated T lymphocytes signalling pathway in hypertensive patients.

Authors:  Sha-Sha Huang; Si-Li He; Yuan-Ming Zhang
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2016-06-17       Impact factor: 1.636

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.